Radius Health PE Ratio 2010-2019 | RDUS

Current and historical p/e ratio for Radius Health (RDUS) from 2010 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Radius Health PE ratio as of September 20, 2019 is 0.00.
Radius Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-20 28.47 0.00
2019-06-30 24.36 $-3.70 0.00
2019-03-31 19.94 $-4.45 0.00
2018-12-31 16.49 $-4.88 0.00
2018-09-30 17.80 $-5.57 0.00
2018-06-30 29.47 $-5.79 0.00
2018-03-31 35.94 $-5.85 0.00
2017-12-31 31.77 $-5.80 0.00
2017-09-30 38.55 $-5.43 0.00
2017-06-30 45.23 $-5.19 0.00
2017-03-31 38.65 $-4.62 0.00
2016-12-31 38.03 $-4.24 0.00
2016-09-30 54.09 $-3.79 0.00
2016-06-30 36.75 $-3.40 0.00
2016-03-31 31.44 $-3.00 0.00
2015-12-31 61.54 $-2.53 0.00
2015-09-30 69.31 $-2.31 0.00
2015-06-30 67.70 $-2.22 0.00
2015-03-31 41.16 $-3.83 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.331B $0.099B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.346B 36.55
Astellas Pharma (ALPMY) Japan $27.779B 13.24
Takeda Pharmaceutical (TAK) Japan $27.107B 8.46
Eisai (ESALY) Japan $14.406B 24.77
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $14.136B 18.03
UCB SA (UCBJF) Belgium $13.914B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.295B 0.00
Ionis Pharmaceuticals (IONS) United States $8.843B 19.07
IPSEN SA ADR (IPSEY) France $8.581B 0.00
Sage Therapeutics (SAGE) United States $8.451B 0.00
Catalent (CTLT) United States $7.395B 29.27
Jazz Pharmaceuticals (JAZZ) Ireland $7.318B 9.63
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.058B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.064B 18.20
United Therapeutics (UTHR) United States $3.768B 0.00
Nektar Therapeutics (NKTR) United States $3.544B 0.00
FibroGen (FGEN) United States $3.446B 86.20
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.093B 11.09
Tilray (TLRY) Canada $2.925B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.758B 63.24
PTC Therapeutics (PTCT) United States $2.304B 0.00
Portola Pharmaceuticals (PTLA) United States $2.065B 0.00
Xencor (XNCR) United States $2.009B 43.80
Zogenix (ZGNX) United States $1.830B 0.00
Heron Therapeutics (HRTX) United States $1.611B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.562B 21.47
USANA Health Sciences (USNA) United States $1.544B 15.49
Pacira Pharmaceuticals (PCRX) United States $1.544B 56.20
Ironwood Pharmaceuticals (IRWD) United States $1.501B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.398B 23.06
Theravance Biopharma (TBPH) Cayman Islands $1.266B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.066B 0.00
Aerie Pharmaceuticals (AERI) United States $1.052B 0.00
ArQule (ARQL) United States $0.964B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.942B 4.20
TherapeuticsMD (TXMD) United States $0.895B 0.00
Endo (ENDP) Ireland $0.761B 1.34
Karyopharm Therapeutics (KPTI) United States $0.701B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.677B 0.00
Concordia (CXRXF) Canada $0.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Flexion Therapeutics (FLXN) United States $0.561B 0.00
Organogenesis Holdings (ORGO) United States $0.553B 0.00
Lannett Co Inc (LCI) United States $0.542B 5.71
Akebia Therapeutics (AKBA) United States $0.537B 0.00
Translate Bio (TBIO) United States $0.515B 0.00
Aptorum Group (APM) China $0.486B 0.00
ImmunoGen (IMGN) United States $0.469B 0.00
Dova Pharmaceuticals (DOVA) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.460B 1.07
Indivior (INVVY) United States $0.459B 1.66
Innate Pharma SA (IPHYF) France $0.455B 0.00
ChemoCentryx (CCXI) United States $0.441B 0.00
Dermira (DERM) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.429B 19.49
Crinetics Pharmaceuticals (CRNX) United States $0.405B 0.00
Collegium Pharmaceutical (COLL) United States $0.390B 0.00
DURECT (DRRX) United States $0.365B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Harpoon Therapeutics (HARP) United States $0.344B 0.00
OptiNose (OPTN) United States $0.322B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.320B 0.00
Ardelyx (ARDX) United States $0.306B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.287B 0.00
Xeris Pharmaceuticals (XERS) United States $0.279B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.279B 0.00
CV Sciences (CVSI) United States $0.274B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.273B 0.00
Recro Pharma (REPH) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
KalVista Pharmaceuticals (KALV) United States $0.253B 0.00
Molecular Templates (MTEM) United States $0.232B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.218B 0.00
Calithera Biosciences (CALA) United States $0.207B 0.00
Ocular Therapeutix (OCUL) United States $0.202B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.200B 0.00
GlycoMimetics (GLYC) United States $0.196B 0.00
CannTrust Holdings (CTST) Canada $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 31.29
Generex Biotechnology (GNBT) United States $0.170B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
IMV INC (IMV) Canada $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
ElectroCore (ECOR) United States $0.147B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.137B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.105B 0.00
Mast Therapeutics (SVRA) United States $0.100B 0.00
Genocea Biosciences (GNCA) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Neos Therapeutics (NEOS) United States $0.086B 0.00
MediWound (MDWD) Israel $0.086B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 31.12
Aquestive Therapeutics (AQST) United States $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 7.44
Lipocine (LPCN) United States $0.072B 0.00
Novan (NOVN) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Jaguar Animal Health (JAGX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
Capnia (SLNO) United States $0.055B 0.00
IntelGenx Technologies (IGXT) Canada $0.052B 0.00
CTI BioPharma (CTIC) United States $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.051B 0.00
Medicure (MCUJF) Canada $0.051B 0.00
Forward Pharma (FWP) Denmark $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.61
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.010B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00